Conference Home

Scientific Agenda

Accommodations & Travel

Sponsorship


OncologyEducation.com’s Best of ASCO® Conference is a program licensed by the American Society of Clinical Oncology and will be held on June 20, 2017 in Montréal, Québec. The focus of this event will be to provide medical oncologists and other healthcare practitioners with a summary of the most significant treatment advances presented at the ASCO 2017 Annual Meeting, with presentations focused on several key disease sites. More details to come.

Meeting Objectives 

1. To summarize the most significant treatment advances presented at ASCO 2017.

2. To review the current standard of care for key malignancies.

3. To discuss the current controversies in the management of speci­fic cancers.

Target Audience

Medical oncologists, pharmacists, nurses, and other oncology healthcare professionals.


Registration

Early bird rates - Deadline: Sunday April 30th
Physician Rate - $129.00
Nurses & Allied Health - $65.00

Standard rates
Physician Rate - $179.00
Nurses & Allied Health - $95.00

register button


Program Chairs

Dr. Michel Pavic, MD

Dr. Pavic is a Medical Oncologist at Centre intégré universitaire de santé et de services sociaux de l'Estrie – Centre Hospitalier Universitaire de Sherbrooke and an assistant professor of the Faculty of Medicine and Health Sciences of the Université de Sherbrooke. He is also the Chief of the Hemato-Oncology department at Hôpital Fleurimont, CIUSS de l’Estrie –CHUS. Dr. Pavic is the lead for numerous courses and training programs in his native France.

His clinical activities focus on hematological, urological, gastrointestinal, and breast cancers and he has participated in several clinical research protocols in venous thrombosis, immunodeficiencies, prostate cancer, and kidney cancer.


Other Information

*This meeting has been approved by the American Society of Clinical Oncology. ASCO is not the CME provider for this activity.

**Best of ASCO® and any related logos are trademarks of the American Society of Clinical Oncology®.


Featured Oncology News

Powered by OBR Oncology